Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.370
-0.070 (-2.03%)
At close: Aug 1, 2025, 4:00 PM
3.420
+0.050 (1.48%)
After-hours: Aug 1, 2025, 7:47 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $121.27 million as of August 1, 2025. Its market cap has increased by 249.54% in one year.
Market Cap
121.27M
Enterprise Value
89.49M
1-Year Change
249.54%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $121.27M, a decrease of -66.85%. That is a compound annual growth rate of -24.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 121.27M | 77.53% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |